corilagin has been researched along with Bone Loss, Osteoclastic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Chen, Y; He, R; Hou, W; Huang, D; Huang, Y; Kuang, Z; Lu, J; Tang, L; Xiao, S; Ye, C; Yishake, M | 1 |
1 other study(ies) available for corilagin and Bone Loss, Osteoclastic
Article | Year |
---|---|
Corilagin suppresses RANKL-induced osteoclastogenesis and inhibits oestrogen deficiency-induced bone loss via the NF-κB and PI3K/AKT signalling pathways.
Topics: Actins; Animals; Bone Marrow Cells; Bone Resorption; Down-Regulation; Estrogens; Glucosides; Hydrolyzable Tannins; Mice; Mice, Inbred C57BL; NF-kappa B; NFATC Transcription Factors; Osteoclasts; Osteogenesis; Osteoprotegerin; Ovariectomy; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; RANK Ligand; RAW 264.7 Cells; Reactive Oxygen Species; RNA, Messenger; Signal Transduction | 2020 |